Related Experiment Video

Updated: Oct 4, 2026

Defining Hsp33's Redox-regulated Chaperone Activity and Mapping Conformational Changes on Hsp33 Using Hydrogen-deuterium Exchange Mass Spectrometry
10:24

Defining Hsp33's Redox-regulated Chaperone Activity and Mapping Conformational Changes on Hsp33 Using Hydrogen-deuterium Exchange Mass Spectrometry

Published on: June 7, 2018

Proteasomal degradation of oxidatively damaged endogenous histones in K562 human leukemic cells

O Ullrich1, T Grune

  • 1Dept. of Cell- and Neurobiology, Institute of Anatomy, Humboldt University Berlin, Schumannstrasse 20/21, D-10098 Berlin, Germany.

Free Radical Biology & Medicine
|October 5, 2001
PubMed

Insights

Tumor cells degrade oxidized histones via the proteasome system, a process linked to cellular stress responses. Inhibiting poly-ADP-ribose-polymerase (PARP) or the proteasome reduces this histone degradation, offering potential therapeutic strategies.

Area of Science:

  • Cellular Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Antitumor drugs induce oxidative damage to nuclear material in tumor cells.
  • Understanding tumor cell responses to nuclear protein oxidation is crucial for cancer therapy.

Purpose of the Study:

  • To investigate the degradation of oxidatively damaged histones in K562 human leukemic cells.
  • To explore the role of poly-ADP-ribose-polymerase (PARP) and the proteasome in this process.

Main Methods:

  • Oxidative challenge applied to K562 cells.
  • Analysis of histone degradation rates.
  • Use of PARP inhibitor (3-aminobenzamide) and proteasome inhibitor (lactacystin).
  • Immunoprecipitation experiments.

Main Results:

  • Oxidative challenge enhanced endogenous nuclear protein and histone degradation.
  • Histone H1 showed the highest degradation rate.
  • Degradation was reduced by the PARP inhibitor and nearly abrogated by the proteasome inhibitor.
  • Proteasomes were shown to specifically degrade oxidized histones.

Conclusions:

  • The nuclear proteasome system prevents oxidized protein accumulation in tumor cells.
  • Targeting proteasome-mediated histone degradation could be a therapeutic strategy against cancer.

More Related Videos

Proximity Ligand Assay to Localize Proteins in DNA Damage Sites09:39

Proximity Ligand Assay to Localize Proteins in DNA Damage Sites

Published on: August 2, 2024

Cycloheximide Chase Analysis of Protein Degradation in Saccharomyces cerevisiae09:05

Cycloheximide Chase Analysis of Protein Degradation in Saccharomyces cerevisiae

Published on: April 18, 2016

Related Concept Videos

The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
The Proteasome Structure01:17

The Proteasome Structure

The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...